Facilitatory and Inhibitory Effects of Harmaline on the Tryptophan-Induced 5-Hydroxytryptamine Syndrome and Body Temperature Changes in Pargyline-Pretreated Rats

Abstract

ABSTRACT-The effects of harmaline on tryptophan-induced 5-hydroxytryptamine (5-HT) syndrome and body temperature changes in pargyline-pretreated rats were investigated. When administered i.p. 60 min after pargyline treatment (50 mg/kg, i.p.), tryptophan, at 100 mg/kg but not 10 mg/kg, induced the 5-HT syndrome. Tryptophan at 100 mg/kg also produced hypothermia followed by hyperthermia in pargylinepretreated rats. Administration of harmaline (10 mg/kg, i.p.) 30 min after pargyline not only potentiated the 100 mg/kg tryptophan-induced 5-HT syndrome and body temperature changes, but also produced the syndrome following administration of 10 mg/kg tryptophan in pargyline-pretreated rats. In contrast, when administered 30 min before pargyline, 10 mg/kg harmaline completely suppressed the syndrome and body temperature changes caused by 100 mg/kg tryptophan. Tryptophan (100 mg/kg, i.p.) administration significantly increased 5-HT levels and decreased 5-hydroxyindole acetic acid levels and 5-HT turnover in the brain of pargyline-pretreated rats. Harmaline administration 30 min after pargyline did not significantly affect the tryptophan-induced changes in 5-HT levels and 5-HT turnover, whereas when administered 30 min before pargyline, harmaline significantly blocked the effect of tryptophan. These results suggest that mechanisms underlying the inhibitory action of harmaline on the tryptophan-induced 5-HT syndrome and body temperature changes in pargyline-pretreated rats differ from those by which harmaline potentiates the effects of tryptophan.

Multi-omics Identify Serotonin Transporter as a Promising Therapeutic Target for Essential Tremor

“…For instance, citalopram, a selective serotonin reuptake inhibitor, has been reported to augment harmaline-induced tremor 35 . Additionally, after harmaline injection, elevated level of 5-HT level was observed in striatum, cortex, hypothalamus, hippocampus 36,37 and brainstem 35 . Furthermore, sertraline escitalopram, one of the SSRI, was implicated in inducing movement disorders, including dystonia, akathisia, parkinsonian symptoms in a 38-year-old male patient 38 .…”

Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

“…11 Harmala alkaloids exhibit reversible and selective inhibition of MAO-A, which differentiates them from irreversible pharmaceutical MAOIs. [18][19][20] Reversible MAOIs, such as moclobemide, have a reduced propensity to lead to serotonin syndrome and hypertensive crises. [21][22][23] Harmine has been shown to produce serotonin syndrome and myoclonic syndrome in rodents injected with tryptophan.…”

Binding affinity and in vitro cytotoxicity of harmaline targeting different motifs of nucleic acids: An ultimate drug designing approach

“…Also, the basic mechanisms of action of these agents on particular molecular targets are poorly understood, or they are simply not directed to a particular target. β‐Carboline alkaloids are such a large group of natural and synthetic indole alkaloids, of great pharmacological significance, including in cancer and tumor treatments; hence, numerous studies have been focused on their biological effects …”